NasdaqGS:INDVPharmaceuticals
Assessing Indivior (INDV) Valuation After New SUBLOCADE Study In Correctional Healthcare
Indivior Pharmaceuticals (INDV) is back in focus after funding a new study suggesting its monthly SUBLOCADE injection may reduce staff time and related costs for treating opioid use disorder in jails and prisons.
See our latest analysis for Indivior Pharmaceuticals.
At a share price of US$30.54, Indivior Pharmaceuticals has a 1 year total shareholder return of about 220%. However, the 90 day share price return of around 10% suggests momentum has cooled recently, setting a cautious tone ahead...